Effectiveness of Non-pharmacological Interventions for Dementia Prevention in Elderly Patients With Mild Cognitive Impairment

Recruiting now · Not applicable

Conditions studied: Mild Cognitive Impairment, Dementia Prevention

In brief

The aims of this study is to evaluate the effectiveness of non-pharmacological interventions program in preventing progression from mild cognitive impairment to dementia in patients with mild cognitive impairment in the short term, at Nhân dân Gia Định Hospital, Hồ Chí Minh City.

Key facts

Study ID

NCT06453746

Run by

Gia Dinh People Hospital

People needed

192

Starts

2024-08-26

Expected to finish

2026-12-01

Last updated by the study team

2024-09-19

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects diagnosed with mild cognitive impairment:
• Cognitive complaints from the subject or a family member.
• Report a decline in cognitive function compared to the subject's previous ability over the past year OR
• Evidence from clinical assessment, specifically here is MMSE screening with results of 24-29 points.
• Subjects did not suffer major impacts from cognitive complaints on daily life.
• No prior diagnosis of dementia.
• Ensure transportation from living location to hospital.
• Have at least one relative or caregiver who can supervise the subject's daily activities.
• Stable chronic underlying conditions (diabetes, hypertension).
• Consent to participate in the study.

You may not qualify if…

• Don't know Vietnamese writing.
• Audio-visual ability does not meet the requirements of assessment tests and prevention programs.
• Systemic diseases are contraindications/ restriction to participation in programs and/or cause secondary cognitive impairment (traumatic brain injury, stroke, brain tumor, parkinsonism, epilepsy, acute coronary artery disease, acute myocardial infarction, bone fractures...).
• The assessment score on the Geriatric Depression Scale (GDS-15) is ≥ 5 points.
• Diagnosed with other mental disorders that may limit the ability to understand, communicate and work in groups (schizophrenia, mania, bipolar disorder, dissociative disorder, generalized anxiety disorder).
• Currently participating in another research program on dementia prevention or a research program on medication to prevent dementia within the last 3 months.
• Taking medications that may affect cognitive function, such as benzodiazepines, hypnotics, and antipsychotics.
• Alcohol abuse: drinking alcohol daily or consuming more than 14 units of alcohol per week (equivalent to 10 grams of ethanol, as defined by the Ministry of Health); diagnosed with alcohol dependence or currently being treated for mental illness due to alcohol dependence.
• Do not agree to participate in the study.

Where it is running

• Nhân dân Gia Định Hospital — Ho Chi Minh City, Vietnam (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.